MATERIAL EVENT4506.TTSE

Sumitomo Pharma: change in parent company or specified subsidiary

Summary

Sumitomo Pharma Co., Ltd. filed an extraordinary report via EDINET on 2025-10-31 16:45 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100WXVD ↗ · PDL1.0 · Not investment advice

Topic	Change in parent company or specified subsidiary
Item	3
Company	Sumitomo Pharma
Filed	2025-10-31 16:45 JST 03:45 ET